Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03733990
Title A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Faron Pharmaceuticals Ltd
Indications

hepatocellular carcinoma

colorectal adenocarcinoma

pancreatic ductal adenocarcinoma

estrogen-receptor positive breast cancer

thyroid gland anaplastic carcinoma

gastric adenocarcinoma

ovarian cancer

skin melanoma

uveal melanoma

esophagus adenocarcinoma

cholangiocarcinoma

gastroesophageal junction adenocarcinoma

ovary serous adenocarcinoma

gallbladder cancer

Therapies

FP-1305

Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
The University of Texas Health Science Center at San Antonio Recruiting San Antonio Texas 78229-3901 United States Details
Clinical Research Institute HUCH Ltd Recruiting Helsinki 00290 Finland Details
Oulu University Hospital Recruiting Oulu 90220 Finland Details
Tampere University Hospital Recruiting Tampere 33520 Finland Details
Turku University Hospital Recruiting Turku 20520 Finland Details
The Institut Gustave Roussy Recruiting Villejuif 94805 France Details
Erasmus University Medical Center Rotterdam Recruiting Rotterdam 3015 GD Netherlands Details
START Madrid - CIOCC Hospital HM Sanchinarro Recruiting Madrid 28050 Spain Details
The Royal Marsden NHS Foundation Trust Recruiting Sutton Surrey SM2 5PT United Kingdom Details
Queen Elizabeth Hospital Birmingham Recruiting Birmingham B15 2GW United Kingdom Details
The Christie NHS Foundation Trust Recruiting Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field